Crispr Therapeutics shares owned by Global Trust Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Global Trust Asset Management
from 13F filings
Historical chart of Global Trust Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Global Trust Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Global Trust Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $24k | 500 | 46.98 |
| 2024-06-30 | $27k | 500 | 54.01 |
| 2024-03-31 | $14k | 200 | 68.16 |
More positions owned by Global Trust Asset Management
View all positions for Global Trust Asset Management